These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22252512)

  • 21. Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats.
    Steinwaerder DS; Carlson CA; Lieber A
    J Virol; 1999 Nov; 73(11):9303-13. PubMed ID: 10516039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.
    Bernt K; Liang M; Ye X; Ni S; Li ZY; Ye SL; Hu F; Lieber A
    J Virol; 2002 Nov; 76(21):10994-1002. PubMed ID: 12368342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing E1 deleted adenoviral vector by homologous recombination.
    Zamani A; Ghannad MS
    Iran Biomed J; 2007 Jul; 11(3):199-202. PubMed ID: 18051781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.
    Robinson M; Ge Y; Ko D; Yendluri S; Laflamme G; Hawkins L; Jooss K
    Cancer Gene Ther; 2008 Jan; 15(1):9-17. PubMed ID: 17853920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.
    Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC
    J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
    Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
    Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
    Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
    Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
    Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M
    J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.
    Zhou H; O'Neal W; Morral N; Beaudet AL
    J Virol; 1996 Oct; 70(10):7030-8. PubMed ID: 8794347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.
    Havenga M; Vogels R; Zuijdgeest D; Radosevic K; Mueller S; Sieuwerts M; Weichold F; Damen I; Kaspers J; Lemckert A; van Meerendonk M; van der Vlugt R; Holterman L; Hone D; Skeiky Y; Mintardjo R; Gillissen G; Barouch D; Sadoff J; Goudsmit J
    J Gen Virol; 2006 Aug; 87(Pt 8):2135-2143. PubMed ID: 16847108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
    Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
    J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
    Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
    Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
    Lieber A; Steinwaerder DS; Carlson CA; Kay MA
    J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
    Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
    J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro.
    Rittner K; Schultz H; Pavirani A; Mehtali M
    J Virol; 1997 Apr; 71(4):3307-11. PubMed ID: 9060700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inclusion of Moloney murine leukemia virus elements upstream of the transgene cassette in an E1-deleted adenovirus leads to an unusual genomic integration in epithelial cells.
    Zheng C; O'Connell BC; Baum BJ
    Virology; 2003 Sep; 313(2):460-72. PubMed ID: 12954213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
    Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binary AdEasy vector systems designed for Tet-ON or Tet-OFF regulated control of transgene expression.
    Berenjian S; Akusjärvi G
    Virus Res; 2006 Jan; 115(1):16-23. PubMed ID: 16102868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
    Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M
    J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs.
    Fang B; Wang H; Gordon G; Bellinger DA; Read MS; Brinkhous KM; Woo SL; Eisensmith RC
    Gene Ther; 1996 Mar; 3(3):217-22. PubMed ID: 8646552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.